Table 7 Changes in antihypertensive mediation in a randomized, placebo-controlled study investigating the effects of cholecalciferol supplementation for 6 months in 50 patients on dialysis
Changes from baseline | ACE-inhibitor | AT2-antagonist | Calcium-antagonist | Beta-blockerA | Fourosemide | Minoxidil | Alfa-blocker | Moxonidine |
|---|---|---|---|---|---|---|---|---|
Placebo | ||||||||
Increased dose (n) | 6 | 4 | 4 | 9 | 6 | 4 | 0 | 0 |
Same dose (n) | 18 | 19 | 19 | 14 | 15 | 16 | 25 | 25 |
Reduced dose (n) | 1 | 2 | 2 | 2 | 4 | 5 | 0 | 0 |
Cholecalciferol | ||||||||
Increased dose (n) | 3 | 5 | 3 | 4 | 7 | 4 | 2 | 1 |
Same dose (n) | 16 | 19 | 18 | 18 | 14 | 18 | 23 | 22 |
Reduced dose (n) | 6 | 1 | 4 | 3 | 4 | 3 | 0 | 2 |